MFN2 and metabolic dysfunction-associated steatohepatitis: For instance, loss of Mfn2 at MAMs disrupts phosphatidylserine transfer, leading to a NASH-like phenotype and liver cancer, thereby demonstrating a causal role for MAM dysfunction in disease pathogenesis (Hernandez-Alvarez et al., 2019).